Frailty is a defined medical syndrome, not just old age — and it is partly reversible

Frailty is not a vague synonym for being old. It is a defined clinical syndrome with measurable criteria, one that independently predicts falls, disability, hospitalisation and death [s1]. And it is, to a degree that surprises people, reversible: the muscle weakness at its core responds to resistance training even in nursing-home residents approaching 90 [s2]. Those two facts — that frailty can be pinned down, and that it can be pushed back — are the reason it has become a central concept in the care of older adults.

What frailty actually is

The most influential definition came from an analysis of 5,317 community-dwelling adults aged 65 and over in the Cardiovascular Health Study [s1]. It operationalised frailty as a phenotype: a person is frail if they meet three or more of five criteria — unintentional weight loss (10 lbs in a year), self-reported exhaustion, weakness measured by grip strength, slow walking speed, and low physical activity [s1]. Meeting one or two criteria marks an intermediate, "pre-frail" state at high risk of progressing [s1].

The prevalence in that population was 6.9%, rising with age and higher in women, with a four-year incidence of 7.2% [s1]. Crucially, the phenotype was independently predictive of falls, worsening mobility and disability, hospitalisation and death, with adjusted hazard ratios ranging from 1.29 to 2.24 — and larger still, from 1.82 to 4.46, before adjustment [s1]. The pre-frail state was not benign either: people with one or two criteria were markedly more likely to become fully frail within three to four years (odds ratio for incident frailty 2.63 after adjustment, 4.51 before) [s1]. The study also drew a line that still matters clinically: frailty is not the same as having multiple diseases or being disabled. Comorbidity is a cause of frailty and disability is an outcome of it, but the syndrome is distinct — which is why a person can be frail without an obvious diagnosis, and why it needs assessing in its own right [s1].

Why "reversible" is the important word

If frailty were simply the body wearing out, there would be little to do. The evidence says otherwise. A randomised trial studied 100 frail nursing-home residents with a mean age of 87 — some as old as 98 — comparing progressive resistance exercise, a nutritional supplement, both, and neither over 10 weeks [s2].

The exercise results were striking. Muscle strength increased by 113% in those who trained, against 3% in non-exercisers (P<0.001) [s2]. Gait velocity — how fast someone walks, a strong predictor of independence — rose 11.8% in exercisers but fell 1.0% in the rest (P=0.02) [s2]. Stair-climbing power improved 28.4% versus 3.6% (P=0.01) [s2]. These are not the numbers of a body beyond help; they are large functional gains, achieved in weeks, in some of the oldest and frailest people studied.

The trial also delivered a caution about the intuitive fix. The nutritional supplement, given without exercise, had no effect on any primary outcome [s2]. Feeding frailty does not treat it; loading the muscles does. That echoes the broader finding on sarcopenia, the age-related muscle loss that underlies much of physical frailty, where resistance training carries far stronger backing than protein powders or drugs.

How to read this

Frailty is best understood as a state to be identified early and acted on, not a verdict. The pre-frail stage — one or two criteria — is where intervention is most promising, before the syndrome consolidates. The action with the strongest evidence is progressive strength training, and the striking part of the data is how late in life it still works. This is not a prescription to start unsupervised exercise; frail older people should build activity with clinical or physiotherapy guidance, particularly if they have fallen or have heart or joint problems.

What to watch

Because exercise is unpatentable, the search for a drug that targets frailty continues — including a philanthropically funded trial of low-dose rapamycin built around frailty as its outcome. Simpler measures are also being tested as risk markers, such as step count before surgery as a predictor of frailty and recovery. Whether any pill matches what resistance training already does in the very old remains the open question.